1. Home
  2. ALMU vs SLN Comparison

ALMU vs SLN Comparison

Compare ALMU & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aeluma Inc.

ALMU

Aeluma Inc.

HOLD

Current Price

$17.60

Market Cap

257.6M

Sector

Technology

ML Signal

HOLD

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$9.21

Market Cap

300.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALMU
SLN
Founded
2019
1994
Country
United States
United Kingdom
Employees
14
88
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
257.6M
300.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ALMU
SLN
Price
$17.60
$9.21
Analyst Decision
Strong Buy
Buy
Analyst Count
3
5
Target Price
$24.67
$42.60
AVG Volume (30 Days)
626.8K
648.2K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$17.49
N/A
Revenue Next Year
$60.61
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.24
$4.19
52 Week High
$31.79
$11.06

Technical Indicators

Market Signals
Indicator
ALMU
SLN
Relative Strength Index (RSI) 37.45 55.24
Support Level $14.70 $5.87
Resistance Level $17.64 $11.06
Average True Range (ATR) 1.71 0.90
MACD -0.49 -0.03
Stochastic Oscillator 8.03 55.45

Price Performance

Historical Comparison
ALMU
SLN

About ALMU Aeluma Inc.

Aeluma Inc is a semiconductor company specializing in sensors and communications. It is developing sensor technology for mobile devices and vehicles. The company develops novel optoelectronic devices for sensing and communications applications. The company manufactures devices using high-performance compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass-market microelectronics. The applications include mobile, automotive, AI, defense & aerospace, communication, AR/VR and quantum computing.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for its internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: